Cannabinoid Pharmacology: Three Decades of Controlled Human Cannabinoid
Controlled drug administration studies are valuable tools for acquiring a detailed understanding of the pharmacodynamic and pharmacokinetic profiles of cannabinoids. ∆9-tetrahydrocannabinoid (THC) is the primary psychoactive cannabinoid in cannabis with the potential to negatively impact cognitive and psychomotor performance and workplace safety. These studies establish behavioral and subjective effect profiles while simultaneously collecting pharmacokinetics data. This information is important for understanding the onset, peak, and duration of effects and their corresponding concentrations in biological fluids. Results from these studies can guide regulations related to workplace drug testing, driving under the influence, post-incident workplace testing, and public health initiatives.
This webinar was hosted by the NIJ Forensic Technology Center of Excellence on August 1, 2023.
Disclaimer:
Opinions or points of view expressed in these recordings represent those of the speakers and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any commercial products and manufacturers discussed in these recordings are presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.